Search Results - "Mueller, Kelly L"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib by Irwin, Mary E., Mueller, Kelly L., Bohin, Natacha, Ge, Yubin, Boerner, Julie L.

    Published in Journal of cellular physiology (01-09-2011)
    “…Epidermal growth factor receptor (EGFR) is overexpressed in many cancer types including ∼30% of breast cancers. Several small molecule tyrosine kinase…”
    Get full text
    Journal Article
  2. 2

    Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met by Mueller, Kelly L, Madden, Julie M, Zoratti, Gina L, Kuperwasser, Charlotte, List, Karin, Boerner, Julie L

    Published in Breast cancer research : BCR (12-07-2012)
    “…Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have shown clinical efficacy in lung, colon, and pancreatic cancers. In lung cancer,…”
    Get full text
    Journal Article
  3. 3

    Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells by Mueller, Kelly L, Hunter, Lauren A, Ethier, Stephen P, Boerner, Julie L

    Published in Cancer research (Chicago, Ill.) (01-05-2008)
    “…Breast cancers are not responsive to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI), although 30% of breast cancers overexpress EGFR…”
    Get full text
    Journal Article
  4. 4

    Protein expression of DNA damage repair proteins dictates response to topoisomerase and PARP inhibitors in triple-negative breast cancer by Boerner, Julie L, Nechiporchik, Nicole, Mueller, Kelly L, Polin, Lisa, Heilbrun, Lance, Boerner, Scott A, Zoratti, Gina L, Stark, Karri, LoRusso, Patricia M, Burger, Angelika

    Published in PloS one (16-03-2015)
    “…Patients with metastatic triple-negative breast cancer (TNBC) have a poor prognosis. New approaches for the treatment of TNBC are needed to improve patient…”
    Get full text
    Journal Article
  5. 5

    EGFR/Met association regulates EGFR TKI resistance in breast cancer by Mueller, Kelly L, Yang, Zeng-Quan, Haddad, Ramsi, Ethier, Stephen P, Boerner, Julie L

    Published in Journal of molecular signaling (12-07-2010)
    “…Breast cancers show a lack of response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs), despite 30% of tumors expressing EGFR. The…”
    Get full text
    Journal Article
  6. 6

    Abrogating phosphorylation of eIF4B is required for EGFR and mTOR inhibitor synergy in triple-negative breast cancer by Madden, Julie M., Mueller, Kelly L., Bollig-Fischer, Aliccia, Stemmer, Paul, Mattingly, Raymond R., Boerner, Julie L.

    Published in Breast cancer research and treatment (01-09-2014)
    “…Triple-negative breast cancer (TNBC) patients suffer from a highly malignant and aggressive disease. They have a high rate of relapse and often develop…”
    Get full text
    Journal Article
  7. 7

    EGFR Tyrosine 845 Phosphorylation-Dependent Proliferation and Transformation of Breast Cancer Cells Require Activation of p38 MAPK by Mueller, Kelly L, Powell, Katelyn, Madden, Julie M, Eblen, Scott T, Boerner, Julie L

    Published in Translational oncology (01-10-2012)
    “…Phosphorylation of epidermal growth factor receptor (EGFR) on tyrosine 845 by c-Src has been shown to be important for cell proliferation and migration in…”
    Get full text
    Journal Article
  8. 8

    A targeted enzyme approach to sensitization of tyrosine kinase inhibitor-resistant breast cancer cells by Giordano, Courtney R., Mueller, Kelly L., Terlecky, Laura J., Krentz, Kendra A., Bollig-Fischer, Aliccia, Terlecky, Stanley R., Boerner, Julie L.

    Published in Experimental cell research (01-10-2012)
    “…Gefitinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) of potential use in patients with breast cancer. Unfortunately, in…”
    Get full text
    Journal Article
  9. 9

    Bicondylar tibial plateau fractures: a biomechanical study by Mueller, Kelly L, Karunakar, Madhav A, Frankenburg, Elizabeth P, Scott, Derek S

    Published in Clinical orthopaedics and related research (01-07-2003)
    “…The optimal treatment of bicondylar tibial plateau fractures remains controversial. The current study was designed to answer the following questions: (1) can a…”
    Get more information
    Journal Article
  10. 10

    Horner's syndrome after posterior spinal fusion in a child : A case report by MUELLER, Kelly L, LODER, Randall T, EGGENBERGER, Eric R, FARLEY, Frances A

    Published in Spine (Philadelphia, Pa. 1976) (01-11-2000)
    “…A case report of a complication after posterior spinal fusion. To present the clinical findings of a Horner's syndrome after posterior spinal fusion. A…”
    Get full text
    Journal Article
  11. 11

    Operative Treatment of Unstable Pediatric Pelvis and Acetabular Fractures by Karunakar, Madhav A, Goulet, James A, Mueller, Kelly L, Bedi, Asheesh, Le, Theodore T

    Published in Journal of pediatric orthopaedics (01-01-2005)
    “…The management of unstable pediatric pelvic and acetabular fractures continues to be controversial. Recent reports have suggested that closed management of…”
    Get full text
    Journal Article
  12. 12

    Spontaneous Respiration Anesthesia for Respiratory Papillomatosis by Stern, Yoram, McCall, John E., Mueller, Kelly L., Willging, J. Paul, Cotton, Robin T.

    Published in Annals of otology, rhinology & laryngology (01-01-2000)
    “…Several anesthetic techniques for microlaryngeal laser surgery in children have been advocated. The objective of this study was to evaluate the operative…”
    Get full text
    Journal Article
  13. 13

    Abstract 2911: EGFR and c-Src crosstalk in breast cancer cell migration by Mueller, Kelly L., Boerner, Julie L.

    Published in Cancer research (Chicago, Ill.) (15-04-2011)
    “…Abstract Patients with breast cancer do not respond to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in the clinic, although 56% of basal…”
    Get full text
    Journal Article
  14. 14

    Abstract 269: Disruption of lipid rafts sensitizes EGFR expressing breast cancer cells to EGFR inhibitors by Irwin, Mary E., Mueller, Kelly L., Boerner, Julie L.

    Published in Cancer research (Chicago, Ill.) (15-04-2010)
    “…Abstract While therapeutic strategies have improved, ∼500,000 women worldwide die from breast cancer each year. Many proteins have been implicated in breast…”
    Get full text
    Journal Article
  15. 15

    Abstract 278: Regulation of constitutive Met phosphorylation in breast cancer by EGFR by Mueller, Kelly L., Haddad, Ramsi, Yang, ZengQuan, Ethier, Stephen P., Boerner, Julie L.

    Published in Cancer research (Chicago, Ill.) (15-04-2010)
    “…Abstract Breast cancer remains a major health problem, despite advances in detection, diagnosis, and treatment. Four genomic subtypes of breast cancer have…”
    Get full text
    Journal Article
  16. 16

    Protein Expression of DNA Damage Repair Proteins Dictates Response to Topoisomerase and PARP Inhibitors in Triple-Negative Breast Cancer: e0119614 by Boerner, Julie L, Nechiporchik, Nicole, Mueller, Kelly L, Polin, Lisa, Heilbrun, Lance, Boerner, Scott A, Zoratti, Gina L, Stark, Karri, LoRusso, Patricia M, Burger, Angelika

    Published in PloS one (01-03-2015)
    “…Patients with metastatic triple-negative breast cancer (TNBC) have a poor prognosis. New approaches for the treatment of TNBC are needed to improve patient…”
    Get full text
    Journal Article
  17. 17

    EGFR Tyrosine 845 Phosphorylation-Dependent Proliferation and Transformation of Breast Cancer Cells Require Activation of p38 MAPK12 by Mueller, Kelly L, Powell, Katelyn, Madden, Julie M, Eblen, Scott T, Boerner, Julie L

    Published in Translational oncology (01-10-2012)
    “…Phosphorylation of epidermal growth factor receptor (EGFR) on tyrosine 845 by c-Src has been shown to be important for cell proliferation and migration in…”
    Get full text
    Journal Article
  18. 18
  19. 19